Bench-to-bedside review: Paediatric viral lower respiratory tract disease necessitating mechanical ventilation - Should we use exogenous surfactant?

Critical Care

Volumn 9, Issue 6, 2005, Pages 550-555

  Kneyber, Martin C J ^a   Plötz, Frans B ^a   Kimpen, Jan L L ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BERACTANT; LUNG SURFACTANT; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID; PLACEBO; PORACTANT; SPHINGOMYELIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

ARTIFICIAL VENTILATION; CHILD; CHILD HEALTH CARE; CHILD HOSPITALIZATION; CLINICAL TRIAL; DATA ANALYSIS; DRUG MECHANISM; DRUG USE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; OXYGENATION; PALLIATIVE THERAPY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SURFACE TENSION; VIRUS INFECTION;

ANIMALS; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFANT; LUNG COMPLIANCE; PEDIATRICS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY TRACT DISEASES; SURFACE TENSION; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 31744447132     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc3823     Document Type: Review

References (50)

1. Hall CB: Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001, 344:1917-1928.
2. Bastien N, Ward D, van Caeselle P, Brandt K, Lee HSS, McNabb G, Klisko B, Chan E, Li Y: Human metapneumovirus infection in the Canadian population. J Clin Microbiol 2003, 41:4642-4646.
3. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, Black S, Shinefield H, Fukuda K: Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000, 342:232-239.
4. Williams JV, Harris PA, Tollefson FJ, Halburnt-Rush LL, Pingersterhaus JM, Edwards KM, Wright PF, Crowe JE Jr: Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004, 350:443-450.
5. Karr C: Bronchiolitis poses significant public health burden. Pediatr Ann 2004, 33:454-459.
6. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ: Bronchiolitis-associated hospitalisations among US children, 1980-1996. JAMA 1999, 282:1440-1446.
7. Wang EE, Law BJ, Boucher FD, Stephens D, Robinson JL, Dobson S, Langley JM, McDonald J, MacDonald NE, Mitchell I: Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalised with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1996, 129:390-395.
8. Guerguian A-M, Farrell C, Gauthier M, Lacroix J: Bronchiolitis: what's next? Pediatr Crit Care Med 2004, 5:498-500.
9. Davison C, Ventre KM, Luchetti M, Randolph AG: Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and mete-analysis. Pediatr Crit Care Med 2004, 5: 482-489.
10. Meyer K, Zimmerman J: Inflammation and surfactant. Paediatr Respir Rev 2002, 3:308-314.
11. Mallory Jr G: Surfactant proteins: role in lung physiology and disease in early life. Paediatr Respir Rev 2001, 2:151-158.
12. Lewis JF, Brackenbury B: Role of exogenous surfactant in acute lung injury. Crit Care Med 2003, 31:S324-S328.
13. Clark HW, Reid KBM, Sim RB: Collectins and innate immunity in the lung. Microbes Infect 2000, 2:273-278.
14. Lewis J, Veldhuizen R: The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 2003, 65:613-642.
15. LeVine AM, Whitsett JA: Pulmonary collectins and innate host defense of the lung. Microbes Infect 2001, 3:161-166.
16. Wright JR: Immunoregulatory functions of surfactant proteins. Nature Rev 2005, 5:58-68.
17. Haagsman HP: Structural and functional aspects of the collectin SP-A. Immunobiol 2002, 205:476-489.
18. Crouch EC: Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998, 19:177-201.
19. Crouch EC: Surfactant protein-D and pulmonary host defense. Respir Res 2000, 1:93-1108.
20. Bourbon JR, Chailley-Heu B: Surfactant proteins in the digestive tract mesentery, and other organs: evolutionary significance. Comp Biochem Physiol 2001, 129:151-161.
21. Dargaville PA, South M, McDougall PN: Surfactant abnormalities in infants with severe viral bronchiolitis. Arch Dis Child 1996, 75:133-136.
22. LeVine AM, Lotze A, Stanley S, Stroud C, O'Donnel R, Whitsett JPollack MM: Surfactant content in children with inflammatory lung disease. Crit Care Med 1996, 24:1062-1067.
23. Skelton R, Holland P, Darowski M, Chetcuti P, Morgan L, Harwood J: Abnormal surfactant composition and activity in severe bronchiolitis. Acta Paediatr 1999, 88:942-946.
24. Kerr MH, Paton JY: Surfactant protein levels in severe respiratory syncytial virus infection. Am J Respir Crit Care Med 1999, 159:1115-1118.
25. van Schaik SM, Vargas I, Welliver RC, Enhorning G: Surfactant dysfunction develops in BALB/c mice infected with respiratory syncytial virus. Pediatr Res 1997, 42:169-173.
26. Luchetti M, Casiraghi G, Valsecchi R, Galassini E, Marraro G: Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anaesthesiol Scand 1998, 42:805-810.
27. Luchetti M, Ferrero F, Gallini C, Natale A, Pigna A, Tortorolo L, Marraro G: Multicenter, randomised, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med 2002, 3:261-268.
28. Tibby SM, Hatherill M, Wright SM, Wilson P, Postle AD, Murdoch IA: Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000, 162:1251-1256.
29. Thomas NJ, Hollenbeak CS, Lucking SE, Willson DF: Cost-effectiveness of exogenous surfactant therapy in pediatric patients with acute hypoxemic respiratory failure. Pediatr Crit Care Med 2005, 6:160-165.
30. Ghildyal R, Hartley C, Varrasso A, Meanger J, Voelker DR, Anders EM, Mills J: Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. J Infect Dis 1999, 180:2009-2013.
31. Hickling TP, Malhotra R, Bright H, McDowell W, Blair ED, Sim RB: Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells. Viral Immunol 2000, 13: 125-135.
32. Sano H, Nagai K, Tstsumi H, Kuroki Y: Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur J Immunol 2003, 33:2894-2902.
33. Weyer C, Sabat R, Wissel H, Kruger DH, Stevens PA, Prösch S: Surfactant protein A binding to cytomegalovirus proteins enhances virus entry into rat lung cells. Am J Respir Cell Mol Biol 2000, 23:71-78.
34. van Iwaarden JF, van Strijp JAG, Ebskamp MJM, Welmers AC, Verhoeff J, van Golde LMG: Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am J Physiol 1991, 261:L204-L209.
35. van Iwaarden JF, van Strijp JAG, Visser H, Haagsman HP, Verhoeff J, van Golde LMG: Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A. J Biol Chem 1992, 267:25039-25043.
36. Hickling TP, Bright H, Wing K, Gower D, Martin SL, Sim RB, Malhotra R: A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur J Immunol 1999, 29:3478-3484.
37. Hartshorn KL, White MR, Voelker DR, Coburn J, Zaner K, Crouch EC: Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem J 2000, 351:449-458.
38. Hartshorn KL, White MR, Shepherd VL, Reid K, Jensenius JC, Crouch EC: Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol 1997, 273:L1156-L1166.
39. Li G, Siddiqui J, Hendry M, Akiyama J, Edmonson J, Brown C, Allen L, Levitt S, Poulain F, Hawgood S: Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a b-resistant strain of influenza A virus. Am J Respir Cell Mol Biol 2002, 26:277-282.
40. Barr FE, Pedigo H, Johnson TR, Shepherd VL: Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages. Am J Respir Cell Mol Biol 2000, 23:586-592.
41. LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T: Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 1999, 103:1015-1021.
42. LeVine AM, Hartshorn KL, Elliott J, Whitsett J, Korfhagen T: Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol 2002, 282:L563-L572.
43. LeVine AM, Whitsett JA, Hartshorn KL, Crouch EC, Korfhagen TR: Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001, 167:5868-5873.
44. Wang SZ, Doyle IR, Nicholas TE, Forsyth KD: Plasma surfactant protein-B is elevated in infants with respiratory syncytial virus-induced bronchiolitis. Pediatr Res 1999, 46:731-734.
45. Haagsman HP, Herias V, van Eijk M: Surfactant phospholipids and proteins in lung defence. Acta Pharmacol Sin 2003, 24: 1301-1303.
46. Fisher J, Kao F, Jones C, White R, Benson B, Mason R: The coding sequence for the 32,000 dalton pulmonary surfactant-associated protein A is located on chromosome 10 and identifies two separate restriction-fragment-length polymorphisms. Am J Human Gen 1987, 40:503-511.
47. DiAngelo S, Lin Z, Wang G, Phillips S, Ramet M, Luo J, Floros J: Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis markers 1999, 15:269-281.
48. Haataja R, Hallman M: Surfactant proteins as genetic determinants of multifactorial pulmonary diseases. Ann Med 2002, 34:324-333.
49. Lofgren J, Ramet M, Renko M, Marttila R, Hallman M: Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 2002, 185: 283-289.
50. Lahti M, Lofgren J, Marttila R, Renko M, Klaavuniemi T, Haataja R, Ramet M, Hallman M: Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002, 51:696-699.